or
forgot password
  • cancer clinical trials in nashville, TN

  • Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Nashville, Tennessee 37064
    Breast Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Tennessee Oncology
    Nashville, Tennessee 37203
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Solid Tumors, Cancer
    Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Breast Cancer
    Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Peripheral Nerve Injury, Prostate Cancer, Radical Prostatectomy, Nerve Reconstruction, Cavernous Nerve Injury
    Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Arthralgia, Breast Cancer
    Study of Blood Samples From Newborns With Down Syndrome
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Leukemia
    Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Leukemia, Lymphoma, Methemoglobinemia, Nonmalignant Neoplasm
    Investigation of Genetic Determinants of Capecitabine Toxicity
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Breast Cancer
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Brain and Central Nervous System Tumors, Neurotoxicity
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
    Vanderbilt Children's Hospital
    Nashville, Tennessee 37232-6310
    Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma
    Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer, Stage III Gastric Cancer, Stage IV Gastric Cancer
    Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Pancreatic Cancer, Periampullary Adenocarcinoma
    Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Lung Cancer
    Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)
    The Vanderbuilt Clinic

    Trial Locations
    The Vanderbuilt Clinic
    Clinical Trials Center
    Acute Myeloid Leukemia
    Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Breast Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Lymphoma, Lymphoproliferative Disorder
    A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
    Sarah Cannon Research Institute SC
    Nashville, Tennessee 37203
    Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication,, Advanced Solid Tumors With FGFR3 Mutation
    Safety Study of PLX108-01 in Patients With Solid Tumors
    Vanderbilt-Ingram Medical Center
    Nashville, Tennessee 37232
    At This Time, All Cohorts Are Closed to Enrollment With the Exception of the Pigmented Villo-nodular Synovitis (PVNS) Cohort.
    Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Severe Thalassemia
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(6)
    Nashville, Tennessee 37203
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Endometrial Papillary Serous Carcinoma, Localized Unresectable Adult Primary Liver Cancer, Metastatic Gastrointestinal Carcinoid Tumor, Ovarian Carcinosarcoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Papillary Serous Carcinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Pulmonary Carcinoid Tumor, Recurrent Adult Primary Liver Cancer, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Cancer, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Regional Gastrointestinal Carcinoid Tumor, Stage IIIA Endometrial Carcinoma, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Endometrial Carcinoma, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Endometrial Carcinoma, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer, Stage IVA Endometrial Carcinoma, Stage IVB Endometrial Carcinoma, Uterine Carcinosarcoma
    A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
    Sarah Cannon Research Institute (SCRI)
    Nashville, Tennessee 37203
    Advanced Solid Tumors
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Meharry Medical College

    Trial Locations
    Meharry Medical College
    Nashville Oncology Associates PC
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
    Vanderbilt Univeristy SC
    Nashville, Tennessee 37232
    Multiple Myeloma
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
    Vanderbilt University Medical Center SC Vanderbilt
    Nashville, Tennessee 37232
    Melanoma
    A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Non Small Cell Lung Cancer
    CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Advanced Hepatocellular Carcinoma, Liver Cancer, Hepatic Cancer, Liver Neoplasms
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies

    Nashville, Tennessee 37203-1632
    Advanced Solid Malignancies
    ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

    Nashville, Tennessee 37203-1632
    Metastatic Colorectal Cancer
    Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Cancer Survivor, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Testicular Germ Cell Tumor
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    SCRI
    Nashville, Tennessee 37203
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    SCRI
    Nashville, Tennessee 37203
    Multiple Myeloma
    Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
    Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC
    Nashville, Tennessee 37212
    Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma